Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Carr

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Vitamins and Hormones|November 25, 2010
Incretin hormone secretion over the dayBo Ahrén, Richard D Carr, Carolyn F Deacon
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
DPP-4 inhibitor therapy: new directions in the treatment of type 2 diabetesCarolyn F Deacon, Richard D Carr, Jens J Holst
American Journal of Physiology. Heart and Circulatory Physiology|February 1, 2011
Antiapoptotic effects of GLP-1 in murine HL-1 cardiomyocytesSusana Ravassa, Amaia Zudaire, Richard D Carr, et al.
International Journal of Mycobacteriology|November 17, 2016
Nontuberculous mycobacterial adenitis outside of the head and neck region in children: A case report and systematic review of the literatureDiego Heraud, Richard D Carr, Jason McKee, et al.
European Journal of Pharmacology|June 24, 2004
The major glucagon-like peptide-1 metabolite, GLP-1-(9-36)-amide, does not affect glucose or insulin levels in miceBidda Rolin, Carolyn F Deacon, Richard D Carr, et al.
Cardiovascular Drugs and Therapy|June 2, 2007
Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathwayAmal K Bose, Mihaela M Mocanu, Richard D Carr, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|October 17, 2008
Overnight hypoxic exposure and glucagon-like peptide-1 and leptin levels in humansEric M Snyder, Richard D Carr, Carolyn F Deacon, et al.
Diabetes|December 28, 2002
Measurements of insulin secretory capacity and glucose tolerance to predict pancreatic beta-cell mass in vivo in the nicotinamide/streptozotocin Göttingen minipig, a model of moderate insulin deficiency and diabetesMarianne O Larsen, Bidda Rolin, Michael Wilken, et al.
Diabetes|September 30, 2003
NN414, a SUR1/Kir6.2-selective potassium channel opener, reduces blood glucose and improves glucose tolerance in the VDF Zucker ratRichard D Carr, Christian L Brand, Thora B Bodvarsdottir, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Beta-cell insulin secretory response to oral hypoglycemic agents is blunted in humans in vivo during moderate hypoglycemiaWaleed Aldhahi, Jen Armstrong, Clara Bouche, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Vitamins and Hormones|November 25, 2010
Incretin hormone secretion over the dayBo Ahrén, Richard D Carr, Carolyn F Deacon
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
DPP-4 inhibitor therapy: new directions in the treatment of type 2 diabetesCarolyn F Deacon, Richard D Carr, Jens J Holst
American Journal of Physiology. Heart and Circulatory Physiology|February 1, 2011
Antiapoptotic effects of GLP-1 in murine HL-1 cardiomyocytesSusana Ravassa, Amaia Zudaire, Richard D Carr, et al.
International Journal of Mycobacteriology|November 17, 2016
Nontuberculous mycobacterial adenitis outside of the head and neck region in children: A case report and systematic review of the literatureDiego Heraud, Richard D Carr, Jason McKee, et al.
European Journal of Pharmacology|June 24, 2004
The major glucagon-like peptide-1 metabolite, GLP-1-(9-36)-amide, does not affect glucose or insulin levels in miceBidda Rolin, Carolyn F Deacon, Richard D Carr, et al.
Cardiovascular Drugs and Therapy|June 2, 2007
Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathwayAmal K Bose, Mihaela M Mocanu, Richard D Carr, et al.
Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquee, Nutrition Et Metabolisme|October 17, 2008
Overnight hypoxic exposure and glucagon-like peptide-1 and leptin levels in humansEric M Snyder, Richard D Carr, Carolyn F Deacon, et al.
Diabetes|December 28, 2002
Measurements of insulin secretory capacity and glucose tolerance to predict pancreatic beta-cell mass in vivo in the nicotinamide/streptozotocin Göttingen minipig, a model of moderate insulin deficiency and diabetesMarianne O Larsen, Bidda Rolin, Michael Wilken, et al.
Diabetes|September 30, 2003
NN414, a SUR1/Kir6.2-selective potassium channel opener, reduces blood glucose and improves glucose tolerance in the VDF Zucker ratRichard D Carr, Christian L Brand, Thora B Bodvarsdottir, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Beta-cell insulin secretory response to oral hypoglycemic agents is blunted in humans in vivo during moderate hypoglycemiaWaleed Aldhahi, Jen Armstrong, Clara Bouche, et al.
Pageof 5